Cargando…

Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses

Mucopolysaccharidoses (MPSs) are rare lysosomal storage diseases caused by the accumulation of undegraded glycosaminoglycans in cells and tissues. The effectiveness of early intervention for MPS has been reported. Multiple-assay formats using tandem mass spectrometry have been developed. Here, we de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oguni, Tsubasa, Tomatsu, Shunji, Tanaka, Misa, Orii, Kenji, Fukao, Toshiyuki, Watanabe, Jun, Fukuda, Seiji, Notsu, Yoshitomo, Vu, Dung Chi, Can, Thi Bich Ngoc, Nagai, Atsushi, Yamaguchi, Seiji, Taketani, Takeshi, Gelb, Michael H., Kobayashi, Hironori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139616/ https://www.ncbi.nlm.nih.gov/pubmed/32188102 http://dx.doi.org/10.3390/ijms21062025

Ejemplares similares

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS
por: Stapleton, Molly, et al.
Publicado: (2020)

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
por: Tomatsu, Shunji, et al.
Publicado: (2014)

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
por: Amendum, Paige C., et al.
Publicado: (2021)

Epidemiology of Mucopolysaccharidoses Update
por: Celik, Betul, et al.
Publicado: (2021)

Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis
por: Orii, Kenji, et al.
Publicado: (2020)

A Simple Flow Injection Analysis–Tandem Mass Spectrometry Method to Reduce False Positives of C5-Acylcarnitines Due to Pivaloylcarnitine Using Reference Ions †
por: Hattori, Takanari, et al.
Publicado: (2022)

Biomarkers in patients with mucopolysaccharidosis type II and IV
por: Fujitsuka, Honoka, et al.
Publicado: (2019)

Comparison of Liquid Chromatography–Tandem Mass Spectrometry and Sandwich ELISA for Determination of Keratan Sulfate in Plasma and Urine
por: Hintze, Jonathan P., et al.
Publicado: (2011)

Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation
por: Suzuki, Yasuyuki, et al.
Publicado: (2020)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
por: Langan, Thomas J., et al.
Publicado: (2020)

Evading the AAV Immune Response in Mucopolysaccharidoses
por: Piechnik, Matthew, et al.
Publicado: (2020)

Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions
por: Wolfberg, Jeremy, et al.
Publicado: (2020)

Ophthalmological Findings in Mucopolysaccharidoses
por: Tomatsu, Shizuka, et al.
Publicado: (2019)

Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
por: Tomatsu, Shunji, et al.
Publicado: (2015)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
por: Viana, Gustavo M., et al.
Publicado: (2020)

Assay for Glycosaminoglycans by Tandem Mass Spectrometry and its Applications
por: Tomatsu, Shunji, et al.
Publicado: (2014)

Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
por: Leal, Andrés Felipe, et al.
Publicado: (2022)

Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
por: Patel, Pravin, et al.
Publicado: (2014)

Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II
por: Orii, Kenji, et al.
Publicado: (2019)

Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II
por: Osaki, Yosuke, et al.
Publicado: (2018)

Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening
por: Shibata, Naoaki, et al.
Publicado: (2018)

A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses
por: Chuang, Chih-Kuang, et al.
Publicado: (2014)

A fetus with mitochondrial trifunctional protein deficiency: Elevation of 3-OH-acylcarnitines in amniotic fluid functionally assured the genetic diagnosis
por: Bo, Ryosuke, et al.
Publicado: (2015)

Serum C14:1/C12:1 ratio is a useful marker for differentiating affected patients with very long-chain acyl-CoA dehydrogenase deficiency from heterozygous carriers
por: Yamada, Kenji, et al.
Publicado: (2019)

To PLEX or Not to PLEX for Amiodarone-Induced Thyrotoxicosis
por: Ahuja, Tania, et al.
Publicado: (2023)

Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21(Cdkn1a) and Pbx1 in Hematopoietic Cells
por: Abe, Mariko, et al.
Publicado: (2016)

ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018)

Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020)

Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021)

A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth
por: Yamada, Kenji, et al.
Publicado: (2017)

The new frame for Mucopolysaccharidoses
por: Parini, Rossella, et al.
Publicado: (2018)

Anesthesiological risks in mucopolysaccharidoses
por: Moretto, Alessandra, et al.
Publicado: (2018)

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

Orthopaedic challenges for mucopolysaccharidoses
por: Borgo, Andrea, et al.
Publicado: (2018)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

Genome Editing for Mucopolysaccharidoses
por: Poletto, Edina, et al.
Publicado: (2020)

Bone Biomarkers in Mucopolysaccharidoses
por: Nakamura-Utsunomiya, Akari
Publicado: (2021)

Growth charts for patients with Hunter syndrome()
por: Patel, Pravin, et al.
Publicado: (2014)

Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA()
por: Chinen, Yasutsugu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i6lftqj9rbp8eio3058k93gsui